*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. In a decision issued on 20 September 2018, the French Competition Authority ("the Authority") sanctioned Sanicorse, jointly and severally with its parent company, SAS Groupe Cesarini, for an abuse of a dominant position in the form of excessive prices. Sanicorse is a company active in the sector of treatment of waste from healthcare activities with infectious risks ("DASRI") in hospitals. The DASRIs are subject to special regulation since the Public Health Code requires healthcare institutions to treat and dispose of them within a set time limit, either by themselves or through a third party. In the present case, Sanicorse was accused of having, between
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.